Merck Animal Health concludes acquisition of Elanco Aqua business Ruchika Sharma12 July 2024 2:44 PM ISTRahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...
USFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck, Daiichi Sankyo Ruchika Sharma28 Jun 2024 10:00 AM ISTRahway: The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA)...
Merck discontinues Phase 3 trial of Xevinapant in locally advanced head and neck cancer Ruchika Sharma27 Jun 2024 5:04 PM ISTGermany: Merck, a science and technology company, has announced the discontinuation of the Phase III randomized TrilynX study evaluating...
Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma18 Jun 2024 2:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Lupin ropes in Abdelaziz Toumi as CEO of its API CDMO Subsidiary Ruchika Sharma18 Jun 2024 12:29 PM ISTMumbai: Global pharma major Lupin Limited has announced the appointment of Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
Focused on second- and third-generation opportunities in cardiometabolic drugs market: Merck Ruchika Sharma12 Jun 2024 1:46 PM ISTMerck emphasized its focus on second- and third-generation opportunities within the cardiometabolic drugs market, including weight-loss therapies, the...
USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma Ruchika Sharma1 Jun 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
MSD Animal Health gets European Commission marketing nod for INNOVAX-ND-H5 vaccine for chickens Ruchika Sharma28 May 2024 9:00 AM ISTRahway: MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, has announced that the European Commission has granted the...
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck Ruchika Sharma11 May 2024 12:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
Merck unveils all-in-one genetic stability assay to accelerate biosafety testing Ruchika Sharma21 April 2024 5:37 PM ISTGermany: Merck, a science and technology company, has launched the all-in-one, validated genetic stability assay of its kind. The Aptegra CHO...
